Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc.’s reported figures.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s EBIT?
- Indivior Pharmaceuticals, Inc. (INDV) reported EBIT of $137M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s EBIT increased by 107.6% year-over-year, from $66M to $137M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s EBIT?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s EBIT has grown at a 50.4% compound annual growth rate (CAGR), from -$77M to $262M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Indivior Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude